Skip to main content
. 2021 Dec 24;9(2):e1126. doi: 10.1212/NXI.0000000000001126

Table 3.

Summary Recommendations for Application of Visual Outcome Measures for Multiple Sclerosis (MS) and Neuromyelitis Optica Spectrum Disorder (NMOSD) Trials Based on the Study Design

graphic file with name NEURIMMINFL2021038746t3.jpg